Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page
- Check5 days agoChange Detected- Revision updated to v3.6.4, replacing v3.6.3. - This reflects a metadata/version change and does not modify the study content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.0, indicating a background update to the site template.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded a recruitment status update indicating no longer looking for participants, and introduced several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). Updated header text for Intervention/Treatment and revised the site revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a new version of the page.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a new version of the page. This update is at the metadata level and does not modify the study details or user-facing content.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.SummaryDifference0.0%

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.